Table 4 Logistic regression analysis of incidence of diarrhoea, stratified by gender, in imatinib treated CML patients. Body mass index (BMI).
Covariate | male imatinib patients | female imatinib patients | |||||
|---|---|---|---|---|---|---|---|
r2 | P value | OR (95% CI) | r2 | P value | OR (95% CI) | ||
Age | 0.002 | 0.589 | 0.994 (0.973, 1.016) | 0.055 | 0.022 | 1.032 (1.005, 1.060) | |
Age (≥ 65) | 0.001 | 0.740 | 0.883 (0.424, 1.841) | 0.030 | 0.084 | 2.091 (0.906, 4.827) | |
BMI | 0.024 | 0.080 | 1.055 (0.994, 1.120) | 0.000 | 0.926 | 1.003 (0.945, 1.064) | |
Platelets | 0.007 | 0.355 | 0.999 (0.998, 1.001) | 0.000 | 0.832 | 1.000 (0.999, 1.001) | |
5-HTTLPR | biallelic | 0.029 | 0.053 | 0.610 (0.370, 1.007) | 0.018 | 0.183 | 0.723 (0.448, 1.166) |
rec | 0.001 | 0.799 | 0.892 (0.369, 2.156) | 0.000 | 0.992 | 0.996 (0.425, 2.331) | |
dom | 0.049 | 0.010 | 2.420 (1.234, 4.744) | 0.042 | 0.042 | 0.470 (0.227, 0.972) | |
rs25531 | biallelic | 0.010 | 0.245 | 1.638 (0.713, 3.766) | 0.003 | 0.616 | 0.771 (0.279, 2.130) |
5-HTTLPR + rs25531 | biallelic | 0.022 | 0.089 | 0.407 (0.407, 1.066) | 0.028 | 0.099 | 0.652 (0.392, 1.084) |
rec | 0.010 | 0.271 | 0.631 (0.278, 1.433) | 0.005 | 0.470 | 1.353 (0.595, 3.075) | |
dom | 0.020 | 0.105 | 1.807 (0.884, 3.694) | 0.038 | 0.053 | 0.449 (0.200, 1.009) | |
STin2 VNTR | triallelic | 0.028 | 0.054 | 1.323 (0.996, 1.758) | 0.009 | 0.338 | 1.185 (0.837, 1.678) |
model B | 0.034 | 0.035 | 1.510 (1.030, 2.212) | 0.003 | 0.561 | 1.143 (0.729, 1.792) | |
model A | 0.021 | 0.099 | 1.479 (0.929, 2.354) | 0.001 | 0.761 | 1.081 (0.656, 1.781) | |
model A rec | 0.017 | 0.129 | 1.933 (0.825, 4.532) | 0.031 | 0.081 | 2.444 (0.895, 6.669) | |
model A dom | 0.012 | 0.221 | 0.658 (0.337, 1.287) | 0.007 | 0.394 | 1.357 (0.672, 2.742) | |
Covariate retained in model | r2 | r2 | |||||
5-HTTLPR dom | 0.059 | — | |||||
Age | — | 0.055 | |||||
Age with 5-HTTLPR + rs25531 dom | — | 0.097 | |||||